Hirst J D, King R D, Sternberg M J
Biomolecular Modelling Laboratory, Imperial Cancer Research Fund, London, U.K.
J Comput Aided Mol Des. 1994 Aug;8(4):421-32. doi: 10.1007/BF00125376.
One of the largest available data sets for developing a quantitative structure-activity relationship (QSAR)--the inhibition of dihydrofolate reductase (DHFR) by 2,4-diamino-6,6-dimethyl-5-phenyl-dihydrotriazine derivatives--has been used for a sixfold cross-validation trial of neural networks, inductive logic programming (ILP) and linear regression. No statistically significant difference was found between the predictive capabilities of the methods. However, the representation of molecules by attributes, which is integral to the ILP approach, provides understandable rules about drug-receptor interactions.
用于建立定量构效关系(QSAR)的最大可用数据集之一——2,4-二氨基-6,6-二甲基-5-苯基二氢三嗪衍生物对二氢叶酸还原酶(DHFR)的抑制作用——已用于神经网络、归纳逻辑编程(ILP)和线性回归的六重交叉验证试验。这些方法的预测能力之间未发现统计学上的显著差异。然而,属性对分子的表示是ILP方法不可或缺的一部分,它提供了关于药物-受体相互作用的可理解规则。